Related Experiment Video
Updated: Mar 30, 2026

05:17
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
9.2K
[Potential Clinical Implications of Circulating Tumor Cells]
1Department of Liver Surgery,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|November 14, 2015
Summary
Circulating tumor cells (CTCs) in blood reflect tumor progression. Detecting CTCs offers a noninvasive method for cancer diagnosis, treatment monitoring, and prognosis prediction.
Area of Science:
- Oncology
- Molecular Biology
- Biomedical Diagnostics
Background:
- Circulating tumor cells (CTCs) originate from primary or metastatic tumors.
- CTCs in peripheral blood can indicate tumor progression and invasiveness.
Purpose of the Study:
- To highlight the clinical significance of CTC detection.
- To explore CTCs as a noninvasive diagnostic and monitoring tool in oncology.
Main Methods:
- Detection of circulating tumor cells (CTCs) in peripheral blood.
- Analysis of CTC features to assess tumor characteristics.
Main Results:
- CTCs correlate with tumor progression and invasiveness.
- CTC detection shows potential for noninvasive cancer diagnosis.
Conclusions:
- CTC detection offers a promising noninvasive approach for cancer diagnosis, drug sensitivity assessment, and treatment monitoring.
- Advancements in cell isolation and molecular identification are key for clinical applications of CTCs.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K

